|
1
|
Seigel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clemente CG, Mihm MC Jr, Bufalino R,
Zurrida S, Collini P and Cascinelli N: Prognostic value of tumor
infiltrating lymphocytes in the vertical growth phase of primary
cutaneous melanoma. Cancer. 77:1303–1310. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mahmoud SM, Paish EC, Powe DG, Macmillan
RD, Grainge MJ, Lee AH, Ellis IO and Green AR: Tumor-infiltrating
CD8+ lymphocytes predict clinical outcome in breast
cancer. J Clin Oncol. 29:1949–1955. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ropponen KM, Eskelinen MJ, Lipponen PK,
Alhava E and Kosma VM: Prognostic value of tumour-infiltrating
lymphocytes (TILs) in colorectal cancer. J Pathol. 182:318–324.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fukunaga A, Miyamoto M, Cho Y, Murakami S,
Kawarada Y, Oshikiri T, Kato K, Kurokawa T, Suzuoki M, Nakakubo Y,
et al: CD8+ tumor-infiltrating lymphocytes together with
CD4+ tumor-infiltrating lymphocytes and dendritic cells
improve the prognosis of patients with pancreatic adenocarcinoma.
Pancreas. 28:e26–e31. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang L, Conejo-Garcia JR, Katsaros D,
Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H,
Schlienger K, Liebman MN, et al: Intratumoral T cells, recurrence,
and survival in epithelial ovarian cancer. N Engl J Med.
348:203–213. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sato E, Oison SH, Ahn J, Bundy B,
Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone
C, et al: Intraepithelial CD8+ tumor-infiltrating
lymphocytes and a high CD8+/regulatory T cell ratio are
associated with favorable prognosis in ovarian cancer. Proc Natl
Acad Sci USA. 102:18538–18543. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Webb JR, Milne K, Watson P, Deleeuw RJ and
Nelson BH: Tumor-infiltrating lymphocytes expressing the tissue
resident memory marker CD103 are associated with increased survival
in high-grade serous ovarian cancer. Clin Cancer Res. 20:434–444.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Loi S, Sirtaine N, Piette F, Salgado R,
Viale G, Van Eenoo F, Rouas G, Francis P, Crown JP, Hitre E, et al:
Prognostic and predictive value of tumor-infiltrating lymphocytes
in a phase III randomized adjuvant breast cancer trial in
node-positive breast cancer comparing the addition of docetaxel to
doxorubicin with doxorubicin-based chemotherapy: BIG 02–98. J Clin
Oncol. 31:860–867. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Herrero-Vicent C, Guerrero A, Gavila J,
Gozalbo F, Hernandez A, Sandiego S, Algarra MA, Calatrava A,
Guillem-Porta V and Ruiz-Simon A: Predictive and prognostic impact
of tumour-infiltrating lymphocytes in triple-negative breast cancer
treated with neoadjuvant chemotherapy. Ecancermedicalscience.
11:7592017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Salgado R, Denkert C, Demaria S, Sirtaine
N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL,
Penault-Llorca F, et al: The evaluation of tumor-infiltrating
lymphocytes (TILs) in breast cancer: recommendations by an
International TILs Working Group 2014. Ann Oncol. 26:259–271. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Loi S, Michiels S, Salgado R, Sirtaine N,
Jose V, Fumagali D, Kellokumpu-Lehtinen PL, Bono P, Kataja V,
Desmedt C, et al: Tumor infiltrating lymphocytes are prognostic in
triple negative breast cancer and predictive for trastuzumab
benefit in early breast cancer: Results from the FinHER trial. Ann
Oncol. 25:1544–1550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Denkert C, von Minckwitz G, Brase JC, Sinn
BV, Gade S, Kronenwett R, Pfitzner BM, Salat C, Loi S, Schmitt WD,
et al: Tumor-infiltrating lymphocytes and response to neoadjuvant
chemotherapy with or without carboplatin in human epidermal growth
factor receptor 2-positive and triple-negative breast cancers. J
Clin Oncol. 33:983–991. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adams S, Gray RJ, Demaria S, Goldstein L,
Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphener TJ, et
al: Prognostic value of tumor-infiltrating lymphocytes in
triple-negative breast cancers from two phase III randomized
adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin
Oncol. 32:2959–2966. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mignon S, Wilard-Gallo K, Van den Eynden
G, Salgado R, Waelput W, Decoster L, Marien K, Vansteenkiste J,
Teugels E and De Greve J: The relationship of TILs and PD-L1
expression in NSCLC adenocarcinoma in little to non-smokers with
driver mutations and outcome parameters. J Thorac Oncol.
12:S13312017. View Article : Google Scholar
|
|
16
|
Kang BW, Seo An, Yoon S, Bae HI, Jeon SW,
Kwon OK, Chung HY, Yi W, Kang H and Kim JG: Prognostic value of
tumor-infiltrating lymphocytes in Epstein-Barr virus-associated
gastric cancer. Ann Oncol. 27:494–501. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sudo T, Nishida R, Kawahara A, Saisho K,
Mimori K, Yamada A, Mizogchi A, Kadoya K, Matono S, Mori N, et al:
Clinical impact of tumor-infiltrating lymphocytes in esophageal
squamous cell carcinoma. Ann Surg Oncol. 24:3763–3770. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahn SG, Jeong J, Hong S and Jung WH:
Current issues and clinical evidence in tumor-infiltrating
lymphocytes in breast cancer. J Pathol Transl Med. 49:355–363.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
James FR, Jiminez-Linan M, Alsop J, Mack
M, Song H, Brenton JD, Pharoah PDP and Ali HR: Association between
tumor infiltrating lymphocytes, histotype and clinical outcome in
epithelial ovarian cancer. BMC Cancer. 17:6572017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tomsová M, Melichar B, Sedlákovál I and
Steiner I: Prognostic significance of CD3+
tumor-infiltrating lymphocytes in ovarian carcinoma. Gynecol Oncol.
108:415–420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hermans C, Anz D, Engel J, Kirhner T,
Endres S and Mayr D: Analysis of FoxP3+ T-regulatory
cells and CD8+ T-cells in ovarian carcinoma: Location
and tumor infiltrating patterns are key prognostic markers. PLos
One. 9:e1117572014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Slaney CY, Kershaw MH and Darcy PK:
Trafficking of T cells into tumor. Cancer Res. 74:7168–7174. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schietinger A, Arina A, Liu RB, Wells S,
Huang J, Engels B, Bindokas V, Bartkowiak T, Lee D, Hermann A, et
al: Longitudinal confocal microscopy imaging of solid tumor
destruction following adoptive T cell transfer. Oncoimmunology.
2:e266772013. View Article : Google Scholar : PubMed/NCBI
|
